<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31545575</article-id><article-id pub-id-type="pmc">6894039</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0343</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Association of Platelet to Lymphocyte and Neutrophil to Lymphocyte Ratios with In-Hospital Mortality in Patients with Type A Acute Aortic Dissection</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3823-2929</contrib-id><name><surname>Bedel</surname><given-names>Cihan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Selvi</surname><given-names>Fatih</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><aff id="aff1">
<label>1</label>University of Health Sciences, Antalya Training and Research Hospital, Department of Emergency Medicine, Antalya, Turkey.</aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: <bold>Cihan Bedel</bold>, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0002-3823-2929">https://orcid.org/0000-0002-3823-2929</ext-link>, University of Health Sciences, Antalya Training and Research Hospital, Varl&#x00131;k Mahallesi, Kaz&#x00131;m Karabekir Street, Muratpa&#x0015f;a, Antalya, Turkey, Zip Code: 07100. E-mail: <email>cihanbedel@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Nov-Dec</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2019</year></pub-date><volume>34</volume><issue>6</issue><fpage>694</fpage><lpage>698</lpage><history><date date-type="received"><day>26</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>14</day><month>2</month><year>2019</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>To evaluate the relationship between neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) with in-hospital mortality in type A acute aortic dissection (AAD).</p></sec><sec><title>Methods</title><p>A total of 96 patients who presented to the emergency department between January 2013 and June 2018 with a diagnosis of type A AAD were enrolled in this study. White blood cell count subtypes such as NLR and PLR were calculated at the time of admission. The end point was in-hospital mortality.</p></sec><sec><title>Results</title><p>Of the 96 type A AAD patients included in this analysis, 17 patients (17.7%) died during hospitalization. NLR and PLR were significantly elevated in patients with type A AAD (<italic>P</italic>&#x0003c;0.001 and &#x0003c;0.001, respectively). Based on the receiver operating characteristic curve, the best NLR cut-off value to predict in-hospital mortality was 9.74, with 70.6% sensitivity and 76.8% specificity, whereas the best PLR cut-off value was 195.8, with 76.5% sensitivity and 78.1% specificity.</p></sec><sec><title>Conclusion</title><p>Admission NLR and PLR levels were important risk factors and independently associated with in-hospital mortality of type A AAD patients.</p></sec></abstract><kwd-group><kwd>Aneurysm, Dissecting</kwd><kwd>Leukocyte Count</kwd><kwd>Lymphocytes</kwd><kwd>Hospital Mortality</kwd><kwd>Blood Platelets</kwd><kwd>Risk Factors</kwd><kwd>Hospitalization</kwd></kwd-group></article-meta></front><body><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AAD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Acute aortic dissection</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">AUC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Area under the curve</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Confidence interval</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CRP</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= C-reactive protein</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">CT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Computed tomography</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">F</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Female</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">M</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Male</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">MPV</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Mean platelet volume</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NLR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Neutrophil to lymphocyte ratio</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PCT</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Plateletcrit</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PDW</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Platelet distribution width</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PLR</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Platelet to lymphocyte ratio</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RDW</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Red cell distribution width</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ROC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Receiver operating characteristic</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Standard deviation</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">SPSS</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Statistical Package for the Social Sciences</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">WBC</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= White blood cell</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Type A acute aortic dissection (AAD) is a destructive cardiovascular condition with a mortality rate of 1-2% per hour, after the onset of symptoms<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Determination of risk factors for prognosis is of great value for risk classification in patients with type A AAD. In recent years, chest pain, hypotension, and inflammatory biomarkers, such as C-reactive protein (CRP), have been shown to be related with the prognosis in patients with AAD<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref>]</sup>.</p><p>White blood cell (WBC) count and its subtypes are widely known as systemic inflammation markers that have been associated with bad clinical outcomes in various cardiovascular diseases<sup>[<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref>]</sup>. Moreover, there are few data regarding the association of neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) with in-hospital mortality in patients with type A AAD. Therefore, we conducted a retrospective clinical study to evaluate the relationship between admission NLR and PLR with in-hospital mortality in patients with type A AAD.</p></sec><sec sec-type="methods"><title>METHODS</title><p>This retrospective study was approved by the local ethical committee and the tenets of the Declaration of Helsinki were followed. After the approval, we carried out a retrospective hospital record review of the data of patients with suspected Stanford type A AAD in our emergency department between January 2013 and June 2018 and these were enrolled in this study. The diagnosis of AAD was confirmed by aorta angiography with multidetector computed tomography (CT) scanning. Inclusion criteria of this study were: (1) type A AAD within 24 hours after symptom onset and (2) age over 18 years. Patients with missing clinical, laboratory, or radiographic data and those who had chronic liver and renal disease, hematological diseases, inflammatory or autoimmune diseases, malignant tumor, and prior history of aortic dissection were excluded. Clinical baseline characteristics, results of CT scan, hematologic laboratory data, and all clinical outcomes were obtained from a review of the each patient&#x02019;s chart in the database of our hospital. The reason and strategy of surgical techniques were determined by the surgeons in the department of cardiovascular surgery in our hospital.</p><p>The laboratory results were evaluated using the first venous blood samples taken on admission to the emergency department. Samples were analyzed within one hour of collection using an automated blood cell counter (Coulter&#x000ae; LH 780 Hematologic Analyzer, Beckman Coulter Inc. Brea, USA). Reference values were 2.1-6.1&#x000d7;10<sup>3</sup>/mm<sup>3</sup> for neutrophils, 1.3-3.5&#x000d7;10<sup>3</sup>/mm<sup>3</sup> for lymphocytes, 156- 373&#x000d7;10<sup>3</sup>/mm<sup>3</sup> for platelets. The NLR was calculated as the ratio of neutrophil count to lymphocyte count, and the PLR was calculated as the ratio of platelet count to lymphocyte count. The study end point was identified as all-cause mortality during hospitalization.</p><sec><title>Statistical Analysis</title><p>We performed all statistical analyses with the Statistical Package for the Social Sciences (SPSS) software (SPSS, Inc., Chicago, Illinois, USA), version 18.0. Results are presented as mean&#x000b1;standard deviation (SD) with interquartile range unless otherwise stated. Variations between interventions are reported as mean differences with 95% confidence intervals (95% CI). Baseline characteristics were compared between survivor and non-survivor patients using unpaired Student&#x02019;s t-tests, Wilcoxon-Mann-Whitney tests for continuous data, and Chi-square tests for categorical data. Categorical variables were defined as a percentage. Receiver operating characteristic (ROC) analysis was performed to determine the cut-off value for NLR and PLR in predicting in-hospital mortality with high sensitivity and specificity. To define the independent predictors associated with in-hospital mortality in AAD patients, univariate analysis and multiple logistic regression analysis were used to identify the factors related to in-hospital mortality.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>A total of 96 patients with a diagnosis of type A AAD were included in the present study. There were 78 (81.2%) male and 18 (18.8%) female patients, with a male to female ratio of 4.3. The mean patients&#x02019; age was 63.7&#x000b1;13.4 years. In-hospital mortality rate was found to be 17.7% (17 of 96 patients). Demographic and laboratory characteristics of survivors and non-survivors were summarized in <xref rid="t1" ref-type="table">Table 1</xref>. In all the non-survivors, the levels of WBC, neutrophil, PLR, and NLR were significantly increased and the levels of lymphocyte were significantly decreased (<italic>P</italic>&#x0003c;0.05), and they were slightly older than survivors. The NLR was 8.5&#x000b1;5.7 in survivor patients and 15.5&#x000b1;10.1 in non-survivor patients (<italic>P</italic>&#x0003c;0.001, <xref ref-type="fig" rid="f1">Figure 1</xref>). The PLR was 182.3&#x000b1;122.9 in survivor patients and 279.3&#x000b1;131.6 in non-survivor patients (<italic>P</italic>&#x0003c;0.001, <xref ref-type="fig" rid="f2">Figure 2</xref>). The NLR values of the patients with and without surgery were 9.1&#x000b1;6.4 and 14.9&#x000b1;11.1, respectively, and the difference between them was not statistically significant (<italic>P</italic>=0.058); the PLR values of the patients with and without surgery were 195.8&#x000b1;133.2 and 231.2&#x000b1;87.1, respectively, and the difference between them was not statistically significant (<italic>P</italic>=0.109). Furthermore, there were no significant differences between the groups in terms of hemoglobin, platelet count, platelet distribution width (PDW), mean platelet volume (MPV), plateletcrit (PCT), red cell distribution width (RDW), and RDW-to-platelets ratio levels.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Clinical characteristics of study population.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="center" rowspan="1" colspan="1">All patients <break/>(n=96)</th><th align="center" rowspan="1" colspan="1">Survivors <break/>(n=79)</th><th align="center" rowspan="1" colspan="1">In-hospital death (n=17)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years; mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">63.7&#x000b1;13.6</td><td align="center" rowspan="1" colspan="1">62.3&#x000b1;12.8</td><td align="center" rowspan="1" colspan="1">70.3&#x000b1;14.6</td><td align="center" rowspan="1" colspan="1">0.030</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender (M/F;%)</td><td align="center" rowspan="1" colspan="1">78/18(81.2/11.8)</td><td align="center" rowspan="1" colspan="1">66/13(83.5/16.5)</td><td align="center" rowspan="1" colspan="1">12/5(70.6/29.4)</td><td align="center" rowspan="1" colspan="1">0.210</td></tr><tr><td align="left" rowspan="1" colspan="1">WBC count (10<sup>3</sup>/mm<sup>3</sup>; mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">12.3&#x000b1;4.7</td><td align="center" rowspan="1" colspan="1">11.7&#x000b1;4.1</td><td align="center" rowspan="1" colspan="1">15.3&#x000b1;6.1</td><td align="center" rowspan="1" colspan="1">0.016</td></tr><tr><td align="left" rowspan="1" colspan="1">Neutrophil count (10<sup>3</sup>/mm<sup>3</sup>; mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">9.9&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1">9.2&#x000b1;3.9</td><td align="center" rowspan="1" colspan="1">10.1&#x000b1;5.8</td><td align="center" rowspan="1" colspan="1">0.006</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphocyte count (&#x000d7;10<sup>3</sup>/mm<sup>3</sup>; mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">1.3&#x000b1;0.6</td><td align="center" rowspan="1" colspan="1">1.4&#x000b1;0.7</td><td align="center" rowspan="1" colspan="1">0.9&#x000b1;0.4</td><td align="center" rowspan="1" colspan="1">0.019</td></tr><tr><td align="left" rowspan="1" colspan="1">Platelet count (&#x000d7;10<sup>3</sup>/mm<sup>3</sup>; mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">220.2&#x000b1;106.9</td><td align="center" rowspan="1" colspan="1">213.2&#x000b1;107.9</td><td align="center" rowspan="1" colspan="1">252.5&#x000b1;99.1</td><td align="center" rowspan="1" colspan="1">0.117</td></tr><tr><td align="left" rowspan="1" colspan="1">PDW (fL; mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">16.1&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">16.1&#x000b1;1.9</td><td align="center" rowspan="1" colspan="1">15.7&#x000b1;2.4</td><td align="center" rowspan="1" colspan="1">0.836</td></tr><tr><td align="left" rowspan="1" colspan="1">MPV (fL; mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">9.2&#x000b1;1.3</td><td align="center" rowspan="1" colspan="1">9.2&#x000b1;1.4</td><td align="center" rowspan="1" colspan="1">9.2&#x000b1;1.3</td><td align="center" rowspan="1" colspan="1">0.744</td></tr><tr><td align="left" rowspan="1" colspan="1">PCT (%; mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">0.2&#x000b1;0.1</td><td align="center" rowspan="1" colspan="1">0.2&#x000b1;0.1</td><td align="center" rowspan="1" colspan="1">0.2&#x000b1;0.1</td><td align="center" rowspan="1" colspan="1">0.849</td></tr><tr><td align="left" rowspan="1" colspan="1">RDW (%; mean&#x000b1;SD)</td><td align="center" rowspan="1" colspan="1">15.3&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">15.4&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">15.1&#x000b1;1.6</td><td align="center" rowspan="1" colspan="1">0.584</td></tr><tr><td align="left" rowspan="1" colspan="1">RDW to platelets ratio</td><td align="center" rowspan="1" colspan="1">0.1&#x000b1;0.07</td><td align="center" rowspan="1" colspan="1">0.1&#x000b1;0.08</td><td align="center" rowspan="1" colspan="1">0.07&#x000b1;0.03</td><td align="center" rowspan="1" colspan="1">0.081</td></tr><tr><td align="left" rowspan="1" colspan="1">PLR</td><td align="center" rowspan="1" colspan="1">199.5&#x000b1;129.2</td><td align="center" rowspan="1" colspan="1">182.3&#x000b1;122.9</td><td align="center" rowspan="1" colspan="1">279.3&#x000b1;131.6</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">NLR</td><td align="center" rowspan="1" colspan="1">9.8&#x000b1;7.2</td><td align="center" rowspan="1" colspan="1">8.5&#x000b1;5.7</td><td align="center" rowspan="1" colspan="1">15.5&#x000b1;10.1</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Surgery (n;%)</td><td align="center" rowspan="1" colspan="1">86(89.6)</td><td align="center" rowspan="1" colspan="1">79(100)</td><td align="center" rowspan="1" colspan="1">7(41.2)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>F=female; M=male; MPV=mean platelet volume; NLR=neutrophil to lymphocyte ratio; PCT=plateletcrit; PDW=platelet distribution width; PLR=platelet to lymphocyte ratio; RDW=red cell distribution width; SD=standard deviation; WBC=white blood cell</p></fn></table-wrap-foot></table-wrap><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Comparison of neutrophil to lymphocyte ratio (NLR) between survivor and non-survivor patients admitted with type A acute aortic dissection.</p></caption><graphic xlink:href="rbccv-34-06-0694-g01"/></fig>
</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Comparison of platelet to lymphocyte ratio (PLR) between survivor and non-survivor patients admitted with type A acute aortic dissection.</p></caption><graphic xlink:href="rbccv-34-06-0694-g02"/></fig>
</p><p>To define the factors which can predict type A AAD related in-hospital mortality, multiple regression analysis was applied using the significant variables from the univariate analysis (<italic>P</italic>&#x0003c;0.05) (<xref rid="t2" ref-type="table">Table 2</xref>). It was found that increased WBC, neutrophil, PLR, NLR, slightly older age, surgical intervention, and decreased lymphocyte were independent predictors of in-hospital mortality in type A AAD (<italic>P</italic>&#x0003c;0.05) (<xref rid="t2" ref-type="table">Table 2</xref>).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Multiple regression analysis of risk factors that affected type A AAD related in-hospital mortality.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Variables</th><th align="center" rowspan="1" colspan="1">Odds ratio</th><th align="center" rowspan="1" colspan="1">95% CI</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">1.071</td><td align="center" rowspan="1" colspan="1">1,016 to 1.130</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">WBC count (&#x000d7;10<sup>3</sup>/mm<sup>3</sup>)</td><td align="center" rowspan="1" colspan="1">2.221</td><td align="center" rowspan="1" colspan="1">0.823 to 5.997</td><td align="center" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">Neutrophil count (&#x000d7;10<sup>3</sup>/mm<sup>3</sup>)</td><td align="center" rowspan="1" colspan="1">0.620</td><td align="center" rowspan="1" colspan="1">0.203 to 1.895</td><td align="center" rowspan="1" colspan="1">0.005</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphocyte count (&#x000d7;10<sup>3</sup>/mm<sup>3</sup>)</td><td align="center" rowspan="1" colspan="1">0.063</td><td align="center" rowspan="1" colspan="1">0.003 to 1,169</td><td align="center" rowspan="1" colspan="1">0.027</td></tr><tr><td align="left" rowspan="1" colspan="1">PLR</td><td align="center" rowspan="1" colspan="1">1.004</td><td align="center" rowspan="1" colspan="1">0.998 to 1.010</td><td align="center" rowspan="1" colspan="1">0.010</td></tr><tr><td align="left" rowspan="1" colspan="1">NLR</td><td align="center" rowspan="1" colspan="1">0.873</td><td align="center" rowspan="1" colspan="1">0.664 to 1.148</td><td align="center" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Surgery</td><td align="center" rowspan="1" colspan="1">2.429</td><td align="center" rowspan="1" colspan="1">1.376 to 4.286</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>AAD=acute aortic dissection; CI=confidence interval; NLR=neutrophil to lymphocyte ratio; PLR=platelet to lymphocyte ratio; WBC=white blood cell</p></fn></table-wrap-foot></table-wrap><p>ROC curve analysis was performed to detect the best cut-off value of NLR and PLR in the prediction of in-hospital mortality in patients with type A AAD (<xref ref-type="fig" rid="f3">Figure 3</xref>). An NLR &#x0003e;9.74 was given an area under the curve (AUC) value of 0.746 (95% CI 0.623-0.870, &#x0003c;0.001). Furthermore, an NLR &#x0003e;9.74 demonstrated a sensitivity of 70.6% and specificity of 76.8% for the prediction of in-hospital mortality. PLR &#x0003e;195.8 was given an AUC value of 0.750 (95% CI 0.638-0.882, &#x0003c;0.001). Furthermore, an PLR &#x0003e;195.8 demonstrated a sensitivity of 76.5% and specificity of 78.1% for the prediction of in-hospital mortality (<xref rid="t3" ref-type="table">Table 3</xref>).</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Receiver operating characteristic (ROC) curve of NLR and PLR for predicting in-hospital mortality in patients with type A acute aortic dissection.</p><p>AUC=area under the curve; NLR=neutrophil to lymphocyte ratio; PLR=platelet to lymphocyte ratio</p></caption><graphic xlink:href="rbccv-34-06-0694-g03"/></fig>
</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Diagnostic accuracy of prognostic parameters to predict type A AAD related in-hospital mortality with the best predictive cut-offs.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">AUC</th><th align="center" rowspan="1" colspan="1">Cut-off value</th><th align="center" rowspan="1" colspan="1">Sensitivity (%)</th><th align="center" rowspan="1" colspan="1">Specificity (%)</th><th align="center" rowspan="1" colspan="1">95% CI</th><th align="center" rowspan="1" colspan="1">P-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">PLR</td><td align="center" rowspan="1" colspan="1">0.750</td><td align="center" rowspan="1" colspan="1">195.8</td><td align="center" rowspan="1" colspan="1">76.5</td><td align="center" rowspan="1" colspan="1">78.1</td><td align="center" rowspan="1" colspan="1">0.638 to 0.882</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">NLR</td><td align="center" rowspan="1" colspan="1">0.746</td><td align="center" rowspan="1" colspan="1">9.74</td><td align="center" rowspan="1" colspan="1">70.6</td><td align="center" rowspan="1" colspan="1">76.8</td><td align="center" rowspan="1" colspan="1">0.623 to 0.870</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>AUC=area under the curve; CI=confidence interval; NLR=neutrophil to lymphocyte ratio; PLR=platelet to lymphocyte ratio</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>This study showed that NLR and PLR are useful predictors of in-hospital mortality in patients with type A AAD. Those who had high NLR and PLR on admission also had high in-hospital mortality. These findings suggest that NLR and PLR can be used as a useful clinical markers for risk classification for type A AAD.</p><p>WBC subtypes, such as NLR and PLR, are simple, widely applied, and inexpensive prognostic markers of proinflammatory state and they appear to be associated with bad clinical outcomes in various cardiovascular diseases<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>]</sup>. Many studies also recommend NLR and PLR as useful predictors of outcomes in percutaneous coronary intervention, coronary artery bypass grafting, and stent restenosis<sup>[<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r9" ref-type="bibr">9</xref>]</sup>. In the present study, we showed that these ratios can be predictive parameters to determine the in-hospital mortality of type A AAD.</p><p>A recent study revealed the relatioship between high NLR levels and significantly high mortality rate. They also found out that the platelet count was an independent predictor of in-hospital mortality<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. In this study, NLR was obtained regarding the differences between the groups to predict in-hospital mortality using ROC analysis. For the NLR, the AUC of this relationship is 0.634, the 95% CI is 0.516-0.753, and the best cut-off NLR was eight, with a sensitivity of 70% and a specificity of 53%. In our study, we found out that using a cut-off point of 9.74, the admission NLR level predicts in-hospital mortality with a sensitivity of 70.6% and a specificity of 76.8% in type A AAD with an AUC value of 0.746 (95% CI 0.623-0.870). But we found out that the platelet count had no independent prognostic factor of in-hospital mortality (<italic>P</italic>=0.117).</p><p>In AAD, which is a separation of the aortic wall layers, the pathogenic, genetic, environmental, and injury factors play an important role<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>. Previous studies have demonstrated that inflammation plays an important role in AAD<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. Recent studies revealed that high PLR levels were associated with inflammation and its severity<sup>[<xref rid="r12" ref-type="bibr">12</xref>,<xref rid="r13" ref-type="bibr">13</xref>]</sup>. In some studies, PLR has been defined as a significant indicator of in-hospital mortality for infective endocarditis, tumors, and cardiovascular diseases<sup>[<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r16" ref-type="bibr">16</xref>]</sup>. Our findings revealed that at a cut-off value &#x0003e;195.8, PLR had an AUC of 0.750, 76.5% sensitivity, and 78.1% specificity in predicting type A AAD related in-hospital mortality.</p><p>Our study had some limitations as follows: (1) this was a single-center study that included a relatively small number of patients who were retrospectively enrolled from our database; (2) we only measured NLR and PLR on admission, so series of NLR and PLR measurements at different time points could also predict type A AAD in-hospital mortality; (3) further research is needed to understand the role of NLR and PLR in the outcome of AAD, alone or in combination with other inflammatory biomarkers.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Admission NLR and PLR levels were important risk factors and independently associated with in-hospital mortality of type A AAD patients.</p><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Author's roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">CB</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design of the study; or the acquisition, analysis, or interpretation of data for the study; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">FS</td><td align="left" rowspan="1" colspan="1">Final approval of the version to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at University of Health Sciences, Antalya Training and Research Hospital, Department of Emergency Medicine, Antalya, Turkey.</p></fn><fn fn-type="financial-disclosure"><p><bold>No financial support.</bold></p></fn><fn fn-type="COI-statement"><p><bold>No conflict of interest.</bold></p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>R</given-names></name><name><surname>Guo</surname><given-names>DC</given-names></name><name><surname>Estrera</surname><given-names>AL</given-names></name><name><surname>Safi</surname><given-names>HJ</given-names></name><name><surname>Huynh</surname><given-names>TT</given-names></name><name><surname>Yin</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections</article-title><source>J Thorac Cardiovasc Surg</source><year>2006</year><volume>131</volume><issue>3</issue><fpage>671</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2005.09.018</pub-id><pub-id pub-id-type="pmid">16515922</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>RH</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Hagan</surname><given-names>PG</given-names></name><name><surname>Bossone</surname><given-names>E</given-names></name><name><surname>Gilon</surname><given-names>D</given-names></name><name><surname>Llovet</surname><given-names>A</given-names></name><etal/></person-group><article-title>Predicting death in patients with acute type A aortic dissection</article-title><source>Circulation</source><year>2002</year><volume>105</volume><issue>2</issue><fpage>200</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1161/hc0202.102246</pub-id><pub-id pub-id-type="pmid">11790701</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakakura</surname><given-names>K</given-names></name><name><surname>Kubo</surname><given-names>N</given-names></name><name><surname>Ako</surname><given-names>J</given-names></name><name><surname>Wada</surname><given-names>H</given-names></name><name><surname>Fujiwara</surname><given-names>N</given-names></name><name><surname>Funayama</surname><given-names>H</given-names></name><etal/></person-group><article-title>Peak C-reactive protein level predicts long-term outcomes in type B acute aortic dissection</article-title><source>Hypertension</source><year>2010</year><volume>55</volume><issue>2</issue><fpage>422</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.109.143131</pub-id><pub-id pub-id-type="pmid">20038755</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>XH</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>HW</given-names></name></person-group><article-title>Association of neutrophil/lymphocyte ratio with long-term mortality after ST elevation myocardial infarction treated with primary percutaneous coronary intervention</article-title><source>Chin Med J</source><year>2010</year><volume>123</volume><issue>23</issue><fpage>3438</fpage><lpage>3443</lpage><pub-id pub-id-type="pmid">22166528</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spark</surname><given-names>JI</given-names></name><name><surname>Sarveswaran</surname><given-names>J</given-names></name><name><surname>Blest</surname><given-names>N</given-names></name><name><surname>Charalabidis</surname><given-names>P</given-names></name><name><surname>Asthana</surname><given-names>S</given-names></name></person-group><article-title>An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia</article-title><source>J Vasc Surg</source><year>2010</year><volume>52</volume><issue>3</issue><fpage>632</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2010.03.067</pub-id><pub-id pub-id-type="pmid">20573475</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhutta</surname><given-names>H</given-names></name><name><surname>Agha</surname><given-names>R</given-names></name><name><surname>Wong</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>TY</given-names></name><name><surname>Wilson</surname><given-names>YG</given-names></name><name><surname>Walsh</surname><given-names>SR</given-names></name></person-group><article-title>Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study</article-title><source>Vasc Endovascular Surg</source><year>2011</year><volume>45</volume><issue>3</issue><fpage>227</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1177/1538574410396590</pub-id><pub-id pub-id-type="pmid">21289130</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azab</surname><given-names>B</given-names></name><name><surname>Shah</surname><given-names>N</given-names></name><name><surname>Akerman</surname><given-names>M</given-names></name><name><surname>McGinn</surname><given-names>JT</given-names></name></person-group><article-title>Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction</article-title><source>J Thromb Thrombolysis</source><year>2012</year><volume>34</volume><issue>3</issue><fpage>326</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1007/s11239-012-0718-6</pub-id><pub-id pub-id-type="pmid">22466812</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azab</surname><given-names>B</given-names></name><name><surname>Zaher</surname><given-names>M</given-names></name><name><surname>Weiserbs</surname><given-names>KF</given-names></name><name><surname>Torbey</surname><given-names>E</given-names></name><name><surname>Lacossiere</surname><given-names>K</given-names></name><name><surname>Gaddam</surname><given-names>S</given-names></name><etal/></person-group><article-title>Usefulness of neutrophil to lymphocyte ratio in predicting short-and long-term mortality after non-ST-elevation myocardial infarction</article-title><source>Am J Cardiol</source><year>2010</year><volume>106</volume><issue>4</issue><fpage>470</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2010.03.062</pub-id><pub-id pub-id-type="pmid">20691303</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turak</surname><given-names>O</given-names></name><name><surname>Ozcan</surname><given-names>F</given-names></name><name><surname>Isleyen</surname><given-names>A</given-names></name><name><surname>Tok</surname><given-names>D</given-names></name><name><surname>Sokmen</surname><given-names>E</given-names></name><name><surname>Buyukkaya</surname><given-names>E</given-names></name><etal/></person-group><article-title>Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis</article-title><source>Am J Cardiol</source><year>2012</year><volume>110</volume><issue>10</issue><fpage>1405</fpage><lpage>1410</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2012.07.003</pub-id><pub-id pub-id-type="pmid">22858185</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laf&#x000e7;i</surname><given-names>G</given-names></name><name><surname>Ci&#x000e7;ek</surname><given-names>&#x000d6;F</given-names></name><name><surname>Uzun</surname><given-names>HA</given-names></name><name><surname>Yal&#x000e7;inkaya</surname><given-names>A</given-names></name><name><surname>Diken</surname><given-names>AI</given-names></name><name><surname>Turak</surname><given-names>O</given-names></name><etal/></person-group><article-title>Relationship of admission neutrophil-to-lymphocyte ratio with in-hospital mortality in patients with acute type I aortic dissection</article-title><source>Turk J Med Sci</source><year>2014</year><volume>44</volume><issue>2</issue><fpage>186</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.3906/sag-1301-136</pub-id><pub-id pub-id-type="pmid">25536722</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>F</given-names></name><name><surname>Zhou</surname><given-names>XL</given-names></name><name><surname>Li</surname><given-names>JJ</given-names></name><name><surname>Hui</surname><given-names>RT</given-names></name></person-group><article-title>Inflammatory response is associated with aortic dissection</article-title><source>Ageing Res Rev</source><year>2009</year><volume>8</volume><issue>1</issue><fpage>31</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.arr.2008.08.001</pub-id><pub-id pub-id-type="pmid">18789403</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>B</given-names></name><name><surname>Ma</surname><given-names>N</given-names></name><name><surname>Tang</surname><given-names>Q</given-names></name><name><surname>Wei</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Fu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients</article-title><source>Mod Rheumatol</source><year>2016</year><volume>26</volume><issue>3</issue><fpage>372</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.3109/14397595.2015.1091136</pub-id><pub-id pub-id-type="pmid">26403379</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DS</given-names></name><name><surname>Shin</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>DY</given-names></name><name><surname>Kim</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis</article-title><source>J Dermatol</source><year>2016</year><volume>43</volume><issue>3</issue><fpage>305</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1111/1346-8138.13061</pub-id><pub-id pub-id-type="pmid">26381893</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zencir</surname><given-names>C</given-names></name><name><surname>Akpek</surname><given-names>M</given-names></name><name><surname>Senol</surname><given-names>S</given-names></name><name><surname>Selvi</surname><given-names>M</given-names></name><name><surname>Onay</surname><given-names>S</given-names></name><name><surname>Cetin</surname><given-names>M</given-names></name><etal/></person-group><article-title>Association between hematologic parameters and in-hospital mortality in patients with infective endocarditis</article-title><source>Kaohsiung J Med Sci</source><year>2015</year><volume>31</volume><issue>12</issue><fpage>632</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1016/j.kjms.2015.10.004</pub-id><pub-id pub-id-type="pmid">26709225</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goh</surname><given-names>BK</given-names></name><name><surname>Chok</surname><given-names>AY</given-names></name><name><surname>Allen Jr</surname><given-names>JC</given-names></name><name><surname>Quek</surname><given-names>R</given-names></name><name><surname>Teo</surname><given-names>MC</given-names></name><name><surname>Chow</surname><given-names>PK</given-names></name><etal/></person-group><article-title>Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors</article-title><source>Surgery</source><year>2016</year><volume>159</volume><issue>4</issue><fpage>1146</fpage><lpage>1156</lpage><pub-id pub-id-type="doi">10.1016/j.surg.2015.10.021</pub-id><pub-id pub-id-type="pmid">26688506</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x0015e;a&#x0015f;k&#x00131;n</surname><given-names>H</given-names></name><name><surname>D&#x000fc;zyol</surname><given-names>&#x000c7;</given-names></name><name><surname>&#x000d6;zcan</surname><given-names>KS</given-names></name><name><surname>Aksoy</surname><given-names>R</given-names></name><name><surname>Idiz</surname><given-names>M</given-names></name></person-group><article-title>Preoperative platelet to lymphocyte ratio is associated with early morbidity and mortality after coronary artery bypass grafting</article-title><source>Heart Surg Forum</source><year>2015</year><volume>18</volume><issue>6</issue><fpage>E255</fpage><lpage>E262</lpage><pub-id pub-id-type="doi">10.1532/hsf.1341</pub-id><pub-id pub-id-type="pmid">26726717</pub-id></element-citation></ref></ref-list></back></article>